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 
Abstract— This paper presents the results of our recent work 
on studying the effects of deep brain stimulation (DBS) and 
medication on the dynamics of brain local field potential (LFP) 
signals used for behavior analysis of patients with Parkinson’s 
disease (PD). DBS is a technique used to alleviate the severe 
symptoms of PD when pharmacotherapy is not very effective.  
Behavior recognition from the LFP signals recorded from the 
subthalamic nucleus (STN) has application in developing 
closed-loop DBS systems, where the stimulation pulse is 
adaptively generated according to subjects’ performing 
behavior. Most of the existing studies on behavior recognition 
that use STN-LFPs are based on the DBS being “off”. This 
paper discovers how the performance and accuracy of 
automated behavior recognition from the LFP signals are 
affected under different paradigms of stimulation on/off. We 
first study the notion of beta power suppression in LFP signals 
under different scenarios (stimulation on/off and medication 
on/off). Afterwards, we explore the accuracy of support vector 
machines in predicting human actions (“button press” and 
“reach”) using the spectrogram of STN-LFP signals. Our 
experiments on the recorded LFP signals of three subjects 
confirm that the beta power is suppressed significantly when 
the patients take medication (p-value<0.002) or stimulation (p-
value<0.0003). The results also show that we can classify 
different behaviors with a reasonable accuracy of 85% even 
when the high-amplitude stimulation is applied. 
Index Terms—Behavior Classification, Deep Brain 
Stimulation, Local Field Potential, Parkinson’s disease, Time-
Frequency Analysis  
I. INTRODUCTION 
Parkinson’s disease (PD) is a neurodegenerative 
condition diagnosed on the basis of clinical history and motor 
signs of tremor, rigidity and bradykinesia (slow movements). 
PD incidence increases with advancing age and peaks among 
people in their 60s and 70s. It is known that in patients with 
PD, the loss of nigral dopaminergic input to the striatum 
leads to motor disorders as a result of augmented beta 
frequency (10–30 Hz) oscillatory power [1]. Lack of 
dopamine in the basal ganglia increases the synchronized 
oscillatory activity in the beta frequency of subthalamic 
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nucleus local field potential (STN-LFP) recordings, which 
correlates with worsening symptoms of PD [2]. 
Deep brain stimulation (DBS) surgery is often used for 
patients with severe signs of PD, specifically when 
pharmacotherapy no longer mitigates the patients’ symptoms 
effectively. The surgical procedure consists of implanting 
DBS leads in the globus pallidum (GPi) or STN of the brain 
for neuro-stimulation by a high-frequency (~130-185 Hz) 
electrical pulse [1]. 
Although DBS is effective in alleviating the motor 
symptoms of PD, it may lead to side effects such as impaired 
cognition, speech, and balance disruptions [3,4]. An adaptive 
(closed-loop) DBS system that modulate the stimulation 
pulse based on the brain feedbacks and patients’ current goal 
may reduce these side effects, while providing maximum 
therapeutic benefit for PD motor symptoms [5,6].   
Recognition of human behavior through brain signals is a 
necessary step to design such a closed-loop system. 
Santaniello et al., [7] proposed a closed-loop DBS system to 
adjust the stimulation amplitude using LFP signals acquired 
from ventral intermediate nucleus (VIM) of the thalamus. 
Loukas and Brown [8] proposed an algorithm to predict self-
paced hand-movements based on the oscillatory nature of the 
STN-LFPs. Time-frequency analysis of the LFP signals in 
the beta frequency range has been used in different studies 
[9-12] to perform the behavior recognition task. 
LFPs recorded from the STN are robust control signals to 
indicate a change in patient’s state [11,13]. Moreover, STN-
LFPs correlate with symptoms of PD, levodopa medication 
level, behavior, and neuro-stimulation intensity [1,14]. PD 
symptoms may vary depending on patient’s level of attention 
and behavior, which change the characteristics of STN-LFP 
activity consequently. Therefore, the chronical variability of 
recorded LFPs must be investigated to design a robust 
closed-loop DBS system.  
In this paper, we chronically recorded STN-LFP from 
three PD subjects in the medication on/off and stimulation 
on/off states while the subjects performed different motor 
tasks such as pressing a button and reaching a target. As a 
consequence, it helps explore the dynamics (i.e., change of 
characteristics) of LFP signals with different therapeutic 
conditions within a long time window. In contrast to our 
previous studies [9-12], where the LFP signals were recorded 
in the operating room, we use a research-grade implantable 
neuro-stimulator (INS) to bilaterally record LFPs outside the 
operating room. Moreover, as opposed to other related works 
[9-12] that utilize the LFP signals with stimulation “off” 
condition, this study aims to evaluate the capability of human 
behavior recognition when stimulation is “on”.  
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Fig. 2. Comparison the effect of medication (left red) and stimulation (right red) on the beta power of LFP signals (blue) recorded from a PD subject 
performing “button press” trials. The graphs are obtained by averaging the PSD of 60 recordings. The highlighted yellow area shows the frequency 
range where the difference between two overlaid graphs (blue and red) is significant (i.e., p-value < 0.05).  
 
 
Fig. 1. Comparison of PSDs between stimulation “off” (red) and “on” 
(blue) cases. As seen, the artifact imposed by the stimulation pulse 
mainly impacts the high frequency range f~(100-180)Hz. At the low 
frequency range, the beta power decreases as a result of the stimulation.  
 
First, the power spectrum density (PSD) of the recorded 
LFPs is analyzed to compare the effect of the medication and 
stimulation pulse on the increased beta power associated with 
PD. Then, we use the time-frequency representation of the 
raw LFP data to design a feature space based on which the 
behavior classification task can be done with both stimulation 
“off” and “on” conditions. We use support vector machine 
(SVM) classifiers to classify “button press” and “reach” trials 
with different compositions of the data, including stimulation 
“off”, “on”, and “off-on combined”. This provides valuable 
insight into the reliability of the classification of LFP signals 
in different stimulation conditions. 
The rest of this paper is organized as follows: Section II 
elaborates on the data recording sessions. The methodology 
is presented in Section III. The quantitative results are given 
in Section IV. Finally, Section V comprises discussion and 
some remarks.   
II. MATERIALS AND DATA RECORDING 
Three PD subjects with an implanted DBS lead 
(Medtronic 3389, Minneapolis, MN, USA) in each STN and 
subcutaneously implanted INS (Activa PC+S, Medtronic 
Inc.,) participated in this study. All participants provided 
informed consent in a manner approved by the HealthOne 
Institutional Review Board.  
All subjects underwent postoperative data recording 
sessions. During the behavioral recording, two bipolar 
referenced LFPs, one from each hemisphere, were amplified 
and digitized (Fs ~ 422Hz) by the INS. In the experiments, 
the bipolar pair of channels containing the most prominent 
peak in beta frequency range was selected for recordings. 
Moreover, the INS generates a stimulation pulse with 
amplitude ~2.5v, frequency ~140Hz, and pulse width ~60μs. 
Recordings were performed at 12 or 24 months after DBS 
lead implantation surgery. The first recording session was 
performed while the subjects refrained from taking their 
levodopa medication for at least 12 hours. The second session 
was performed when the subjects were regularly consuming 
their prescribed medication dosage. On average, behavioral 
tasks included 60 repetitions of cued “button press” and 
“target reaching” trials performed by left or right hands, 
under stimulation “off” and “on” conditions.   
III. METHODOLOGY 
In this section, first, the effect of the medication and 
stimulation pulse on the beta power will be presented. Then, 
we explain the feature extraction and classification approach.  
A.  Analysis of Power Spectrum Density (PSD) 
To compare the therapeutic effect of medication and 
stimulation on the increased beta power associated with PD, 
the power spectrum density (PSD) of the recorded LFPs are 
calculated using a custom Welch’s method with a Hanning 
window of length nfft = Fs. This provides a frequency 
resolution (Fs / nfft) of 1Hz. The PSD of an LFP signal x(t) is 
given by its corresponding discrete Fourier transform 𝑋(𝑓) 
coefficients as follows [15]:  
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where, S is the scaling factor defined as the sum of squared 
weights (ω) of the employed window (Hanning window).  
The impact of stimulation on the PSD of an exemplary 
LFP signal is given in Fig. 1. As shown, there is a significant 
peak about the stimulation frequency (f~140Hz), which has 
been propagated into its neighbor frequency components 
f~(100-180)Hz. However, the low frequency range is not 
considerably affected by the stimulation pulse, except for the 
expected therapeutic decrease on the beta power. 
To evaluate the effect of medication and stimulation pulse 
on the beta power of PD patients, we use the one-way 
analysis of variance (ANOVA) statistical test. In this way, 
the significance of difference between the beta power for 
each case, (medication off vs medication on) and (stimulation 
  
TABLE I. COMPARISON OF CLASSIFICATION PERFORMANCE (%) IN CLASSIFYING “BUTTON PRESS” AND “REACH” TRIALS WITH DIFFERENT 
COMPOSITIONS OF LFP DATA, INCLUDING STIMULATION “OFF”, “ON”, AND “OFF-ON COMBINED”. THE BEST RESULTS ARE HIGHLIGHTED IN EACH CASE. 
 
SVM-Linear SVM-RBF KNN (K=3) 
Accuracy Precision Recall AUC Accuracy Precision Recall AUC Accuracy Precision Recall AUC 
Stim-off 84 84 83 91 87 88 88 94 85 87 82 84 
Stim-on 81 82 80 89 85 85 84 92 81 84 79 81 
Stim-off & on 84 84 83 90 87 87 88 94 83 84 82 84 
 
  
Fig. 3. The average amplitude of wavelet coefficients calculated for LFP signals of 60 “reach” trials. The results are shown for a time interval (-2,1.5)sec 
around each onset centered on 0sec. Left and right respectively shows the spectrogram obtained under stimulation “off” and “on” conditions. Consider the 
similarity of patterns at the beta frequency (both figures) and the artifact generated by the stimulation at f~(100-200)Hz (right). 
off vs stimulation on), can be measured (see Fig. 2). The 
quantitative results are presented in Section IV. 
B.  Classification under Stimulation off and on conditions 
 The time-frequency representation of the raw LFP 
signals is a reliable feature space to distinguish different 
human behaviors [9-12]. Hence, we use continuous wavelet 
transform (CWT) of the recorded LFPs to generate a feature 
space based on which the behavior classification task can be 
done. A complex Morlet wavelet function (𝜓(𝑡) =
 exp (−𝑡2 𝑓𝑏⁄ )exp (𝑗2𝜋𝑓𝑐𝑡) √𝜋𝑓𝑏⁄ ; fc: central frequency, fb: 
bandwidth) is employed to obtain the time-frequency 
representation of the data. Fig. 3 shows the average 
amplitude of the CWT coefficients of all 60 trials recorded 
form one of the subjects and “reach” task. As seen, except for 
some artifacts appeared at high-frequency components (i.e., 
about the stimulation frequency f~140Hz), the spectrograms 
given for both stimulation “off” and “on” cases follow the 
same patterns. It suggests that, regardless of the stimulation 
status, the behavior classification task can be done properly 
as long as the low frequency components are used.  
In this paper, we employ the SVM classifier [16] for the 
behavior classification purpose. The SVM classifier tends to 
separate dataset (𝐷 = {𝐱𝑖 , 𝑦𝑖}𝑖=1
𝑁 ,  𝐱𝑖 ∈ 𝑅
𝑑 , 𝑦𝑖 ∈ {−1, +1}) by 
learning an optimal hyperplane 〈𝐰, 𝐱〉 + 𝑏 = 0 between 
classes such that the margin between them becomes 
maximum; where, w and b are the parameters of the 
hyperplane, ⟨∙,∙⟩ denotes inner product operation, 𝐱𝒊 and y𝑖 
respectively represent the i
th
 sample and its corresponding label. 
In general, the classifier is obtained by minimizing the following 
equation with respect to w: 
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where, ξi ≥ 0 and C ≥ 0 are respectively the slack and penalty 
variables. αi is the Lagrangian multiplier, sgn(∙) is the sign 
function, and 𝑘(∙,∙) is a kernel function to project the data on 
a new space where the linear classification becomes possible.  
IV. EXPERIMENTS AND RESULTS 
In this section, first, the performance of the proposed 
wavelet-based feature space in classifying two behavioral 
tasks (“button press” and “reach”) under stimulation “off”, 
“on”, and “off-on combined” conditions is examined. To this 
end, the beta frequency components of the raw LFPs acquired 
from three PD subjects (Section II) are calculated within an 
interval (-1,1)sec around each task onset. To keep the 
computational burden low, principal component analysis 
(PCA) is applied on the calculated feature vectors before 
exposing them to the classifier [11]. In our experiments, 95% 
of the eigenvalues corresponding to the maximum variance 
direction is kept with the PCA calculations.    
The quantitative results given by the SVM classifier with 
RBF kernel (k(x, y) = exp(γ||x–y||2) and linear kernel (k(x, y) 
= x
T
y+c)), as well as KNN classifier are tabulated in Table I. 
In each case, the classification accuracy (truly predicted 
labels /ground-truth), precision (true positive / (true positive 
+ false positive)), recall (true positive / (true positive + false 
negative)), and AUC (area under the receiver operating 
characteristic curve) are reported. Note that the parameters of 
the classifiers are experimentally set so as to achieve the best 
performance, i.e., linear-SVM C = 100; RBF-SVM C = 100 
and γ = 0.001; KNN K = 3.  
As Table I shows, the RBF-SVM classifier returns the 
best results for the quantitative measures. The results 
obtained under stimulation “on” case are comparable to the 
results of stimulation “off” case, with a margin of 2%. It 
shows that, regardless of the artifact imposed by the high-
amplitude stimulation pulse, the behavior classification can 
be done using the informative beta band patterns. Moreover, 
the classification performance approximately remains 
unchanged when then stimulation “off-on combined” case is 
compared to stimulation “off” case (the stimulation “on” data 
gives very competitive results). For instance, the 
  
 
Fig. 4. Variations of p-values with respect to the frequency range for 
“reach” trial. (Blue) and (red) graphs respectively depict the significance 
of difference (between medication “off” & “on” while stimulation is “off”) 
and (between stimulation “off” & “on” while medication is “off”). As 
seen, p-values remain less than 0.05 for the entire beta range f~(10-30)Hz 
when the stimulation pulse is on (red). 
 
classification accuracy is 87%, 85%, and 87% under 
stimulation “off”, “on”, and “off-on combined” conditions. 
In addition, the efficiency of medication and stimulation 
on the beta power of PD patients is separately compared here. 
Based on our analysis on the PSD of the raw LFP data 
calculated within an interval (-0.5,0.5)sec around each task 
onset, the increased beta power associated with PD is 
significantly reduced under medication (p-value < 0.002)  
and stimulation pulse (p-value < 0.0003). Note that the p-
values are calculated based on the average p-values of a 
frequency interval around the peak of PSDs (i.e., ~fpeak±5 Hz) 
across all subjects and trials. For instance, the frequency 
range of f~(10-20)Hz is used for Fig. 2. 
Considering the experimental results, the beta power 
decrease is more significant in almost all cases when the 
stimulation pulse is “on”. As opposed to the medication “on” 
cases, the p-values remains below 0.05 approximately 
throughout the beta frequency range when the stimulation 
pulse is applied (see Fig. 4). This fact can show the 
prominence of the stimulation pulse over the medication 
therapy in tackling the PD symptoms.   
IV. CONCLUSION AND DISCUSSION 
In this paper, the effect of the stimulation pulse and 
medication on the human behavior classification and beta 
power of Parkinson’s disease (PD) patients was evaluated. A 
feature space based on the time-frequency representation of 
the acquired brain subthalamic nucleus local field potential 
(STN-LFP) signals was developed. Our analysis showed that 
the beta frequency components of LFPs are capable of 
detecting different human activities even when the high-
amplitude deep brain stimulation (DBS) pulse is applied.  
Different experiments were carried out on the LFP signals 
acquired from three PD subjects to classify “button press” 
and “reach” trials. The performance of behavior classification 
was evaluated under stimulation “off”, “on”, and “off-on 
combined” conditions. The results showed that, regardless of 
the stimulation status, the behavior classification capability 
remains almost unchanged when the beta frequency 
components of the proposed feature space are used. As a 
result, there is no need to remove the high-frequency artifacts 
imposed by the stimulation pulse, which essentially requires 
more computational power.  
Furthermore, the effect of stimulation and medication on 
the beta power of LFP signal was separately investigated. 
The results showed that the stimulation artifact mainly 
impacts the frequency range around the stimulation 
frequency. Also, the increased beta power associated with PD 
is suppressed significantly when the patients take medication 
or receive therapeutic stimulation. 
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